Sustained dilatation of large coronary artery by α-human atrial natriuretic peptide in conscious dogs: a comparison with nitroglycerin

This publication has 22 references indexed in Scilit:

• Effects of atrial natriuretic peptide on coronary vascular resistance in the intact awake dog
  Journal of the American College of Cardiology, 1988
• Alpha-human atrial natriuretic peptide is a coronary vasodilator in the Langendorff-perfused guinea pig heart
  Life Sciences, 1988
• Atrial natriuretic peptide during pacing in controls and patients with coronary arterial disease
  International Journal of Cardiology, 1987
• Atrial natriuretic factor and cyclic guanosine 3',5'-monophosphate in vascular smooth muscle.
  Hypertension, 1986
• Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man
  Life Sciences, 1986
• Coronary Vasoconstrictor Effects of Atriopeptin II
  Science, 1985
• Effects of atrial natriuretic factor, sodium nitroprusside, and acetylcholine on cyclic GMP levels and relaxation in rat aorta
  European Journal of Pharmacology, 1985
• Stimulation of cyclic GMP formation in smooth muscle cells by atriopeptin II.
  Life Sciences, 1985
• Vascular receptor binding activities and cyclic GMP responses by synthetic human and rat atrial natriuretic peptides (ANP) and receptor down-regulation by ANP
  Biochemical and Biophysical Research Communications, 1985
• Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP)
  Biochemical and Biophysical Research Communications, 1984